GlassScriptPhysician profile
Stacy Pamela Salob
NPI 1194776435
$2,407.14
in general payments reported to CMS, 2019-2025
18 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $116 · 2021: $11.05 · 2022: $184 · 2023: $707 · 2024: $691 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,521 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,520.94 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $379.42 | 2019-2025 | |
| Janssen Biotech, INC. | $374.54 | 2023-2025 | Tremfya, Simponi Aria, Remicade |
| Abbvie INC. | $271.51 | 2019-2025 | Rinvoq, Skyrizi |
| Genzyme Corporation | $271.11 | 2019-2024 | |
| Lilly USA, LLC | $240.55 | 2020-2025 | Taltz, Ebglyss, Zepbound |
| Ucb, INC. | $189.31 | 2022-2025 | Bimzelx, Cimzia |
| Galderma Laboratories, L.P. | $164.28 | 2019-2024 | Dysport |
| Pfizer INC. | $127.29 | 2019-2024 | |
| Leo Pharma INC. | $100.49 | 2019-2020 | |
| Biofrontera INC. | $54.79 | 2019-2023 | Ameluz, Xepi, Bf-Rhodoled |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $53.68 | 2019 | |
| Allergan, INC. | $35.25 | 2019-2022 | |
| Amgen INC. | $27.97 | 2024 | Otezla |
| Incyte Corporation | $25.97 | 2023 | Opzelura |
| Journey Medical Corporation | $25.68 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $24.76 | 2023 | Dupixent |
| Encore Dermatology INC. | $21.68 | 2019 | |
| Mylan Pharmaceuticals INC. | $18.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Salob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.